WHAT'S NEW

Toronto, September 9, 2020 – MORSE Consulting is pleased to announce that Sal Cimino has joined our team as Senior Consultant, Private Drug Plans. The private payer market is playing an increasingly important role in ensuring a product’s reimbursement success in Canada. With the introduction of new specialty biologics and gene therapies, private payers are turning to new cost containment strategies that strongly resemble … Read More →

Toronto, February 18, 2020 – MORSE Consulting is pleased to expand and strengthen our service offering with the addition of Anita Carrie and Roy Cairns. Affordability of effective and innovative medications within the current Canadian public funding model is becoming very challenging for the healthcare system.  Increasing budgetary constraints coupled with complex treatments requiring consideration of different sources and levels of evidence are an … Read More →

  Happy Holidays from MORSE Consulting! As we enter the holiday season and the close of MORSE’s third year of operation, we wish to express our heartfelt gratitude to the Pharmaceutical Market Access community. We wish you a safe, peaceful, and enjoyable holiday season and the very best for 2020!   —   Read More →

Toronto, October 9, 2018 –MORSE Consulting is pleased to announce the addition of Anita Gadhok as Senior Consultant. With more than 20 years of experience, Anita has worked with provincial drug programs, cancer agencies, private insurance, and community pharmacies in both Ontario and Manitoba. She has been involved in a number of ground-breaking initiatives including precursor work to support the development of the pan-Canadian … Read More →

MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place from April 15-17, 2018 in Halifax, Nova Scotia. Further details on MORSE, and its strategic partner’s (Cornerstone Research Group) participation can be found below. April 16, 2018   15:15-16:30 ADT   Sherry O’Quinn moderates a panel on oncology drugs with Alex Chambers … Read More →

  Toronto, February 7, 2018: Cornerstone Research Group and MORSE Consulting are pleased to announce the creation of a strategic partnership between our two organizations. This strategic partnership will simplify the logistical process for our clients utilizing our combined services when shepherding a product from reimbursement strategy, to CADTH submission and finally to pCPA negotiations. Together the collaboration between Cornerstone and MORSE offers … Read More →

Toronto, January 8, 2018 – Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting is delighted to announce that Brad Alyward has joined our team as Principal Consultant. Brad has 20 years of work experience – initially as a business analyst and project manager in the consulting, IT services and oil and gas industries and more recently as a pharmacist and business operations manager with the Nova … Read More →

Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team as a Senior Advisor. Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and pharmaceutical and biotechnology industry. Her experience spans sales, marketing, market access, government relations and patient advocacy. Therapeutic areas … Read More →

Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE LINKS provides a comprehensive list of useful web links which can allow market access professionals to easily access frequently referenced web sites. Similar to other services offered by MORSE, LINKS has a user-friendly interface with information separated into broad categories to allow … Read More →